Zeiss Announces FDA Clearance of the Quatera 700 Phaco Device

Zeiss announced that the FDA has cleared the Quatera 700, which includes the Zeiss patented Quattro Pump designed to deliver chamber stability independent of IOP and flow.

“What excites me the most about the Quatera 700 is the Quattro pump’s synchronized fluidics system and how I can have both the highest levels of efficiency, while maintaining an extremely stable chamber, independent of IOP,” Sri Ganesh, MD, Chairman and Managing Director of Nethradhama Super Speciality Eye Hospital, Bangalore (India), said in a company news release.

The Zeiss Quatera 700 is designed to increase a surgeon’s workflow efficiency from the clinic to the operating room (OR), enabling one digitally integrated surgical workflow. It works as a single sterile OR dashboard integrating patient data from other systems and the microscope view, available in real-time for the OR staff.

“It’s great to see that Zeiss has added another critical piece to the cataract workflow, a digital solution that further enables us to become more efficient and effective during surgical procedures,” said Elizabeth Yeu, MD, Virginia Eye Consultants, Norfolk, Virginia (USA).

“Zeiss is committed to bringing our latest innovations to the United States, and the Zeiss Quatera 700 is a great example of how integrated technology can drive efficiency in ophthalmology,” Euan S. Thomson, PhD, President of Ophthalmic Devices and Head of the Digital Business Unit for Carl Zeiss Meditec, said in the news release. “Together with our Zeiss Medical Ecosystem and surgical planning software, we believe this fully connected and integrated approach will help set new standards for patient care and clinical management.”